Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China
· Delayed Price · Currency is CNY 13.78
-0.35 (-2.48%)
Jun 6, 2025, 3:00 PM CST
SHA:600557 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 339.94 | 391.86 | 464.16 | 434.47 | 320.54 | 262.92 | Upgrade
|
| Depreciation & Amortization | 196.38 | 196.38 | 194.88 | 189.83 | 187 | 159.58 | Upgrade
|
| Other Amortization | 8.38 | 8.38 | 5.71 | 3.65 | 4.08 | 1.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.7 | -0.7 | -0.76 | -1.38 | -0.97 | 0.3 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.81 | 1.81 | 2.65 | 0.53 | 2.81 | 0.23 | Upgrade
|
| Loss (Gain) From Sale of Investments | -20.9 | -20.9 | -14.79 | -4.2 | -4.06 | -2.71 | Upgrade
|
| Provision & Write-off of Bad Debts | -3.25 | -3.25 | 0.12 | 2.07 | -0.64 | 1.16 | Upgrade
|
| Other Operating Activities | -31.06 | 31.96 | 5.18 | 8.74 | 13.56 | 31.72 | Upgrade
|
| Change in Accounts Receivable | 426.77 | 426.77 | 412.01 | -37.18 | 360.36 | 486.19 | Upgrade
|
| Change in Inventory | -210.9 | -210.9 | -11.65 | -4.22 | 39.92 | -99.21 | Upgrade
|
| Change in Accounts Payable | -116.94 | -116.94 | -54.92 | 402.82 | -15.23 | -139.22 | Upgrade
|
| Operating Cash Flow | 587.54 | 702.49 | 972.32 | 995.94 | 908.3 | 701.1 | Upgrade
|
| Operating Cash Flow Growth | -52.03% | -27.75% | -2.37% | 9.65% | 29.55% | -24.26% | Upgrade
|
| Capital Expenditures | -449.93 | -476.69 | -311.29 | -211.09 | -171.52 | -190.32 | Upgrade
|
| Sale of Property, Plant & Equipment | 9.09 | 9.18 | 2.07 | 21.92 | 29.23 | 0.4 | Upgrade
|
| Divestitures | - | 10.25 | - | - | - | - | Upgrade
|
| Investment in Securities | 368.41 | 420 | -260.45 | 21.07 | -158.5 | 99.42 | Upgrade
|
| Other Investing Activities | 15.68 | 22.56 | 14.8 | 4.16 | 4.04 | 17.57 | Upgrade
|
| Investing Cash Flow | -56.74 | -14.69 | -554.88 | -163.94 | -296.76 | -72.92 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 392 | 944.5 | Upgrade
|
| Total Debt Issued | - | - | - | - | 392 | 944.5 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -234.5 | -645.5 | -1,142 | Upgrade
|
| Total Debt Repaid | - | - | - | -234.5 | -645.5 | -1,142 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -234.5 | -253.5 | -197 | Upgrade
|
| Issuance of Common Stock | - | - | 4.86 | 64.7 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -180 | - | Upgrade
|
| Common Dividends Paid | -211.22 | -213.58 | -128.51 | -2.49 | -11.05 | -68.42 | Upgrade
|
| Other Financing Activities | -274.42 | -288.54 | 75.36 | 4 | 1.64 | -2.19 | Upgrade
|
| Financing Cash Flow | -485.64 | -502.12 | -48.29 | -168.29 | -442.91 | -267.61 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.15 | 0.15 | 0.06 | 0.15 | - | - | Upgrade
|
| Net Cash Flow | 45.31 | 185.82 | 369.21 | 663.86 | 168.63 | 360.57 | Upgrade
|
| Free Cash Flow | 137.61 | 225.8 | 661.03 | 784.85 | 736.77 | 510.78 | Upgrade
|
| Free Cash Flow Growth | -83.50% | -65.84% | -15.78% | 6.53% | 44.24% | 17.24% | Upgrade
|
| Free Cash Flow Margin | 4.03% | 5.79% | 13.59% | 18.04% | 20.19% | 16.85% | Upgrade
|
| Free Cash Flow Per Share | 0.23 | 0.39 | 1.14 | 1.35 | 1.29 | 0.85 | Upgrade
|
| Cash Income Tax Paid | 337.43 | 416.7 | 577.46 | 516.83 | 361.61 | 429.43 | Upgrade
|
| Levered Free Cash Flow | 459.63 | 173.3 | 714.46 | 595.54 | 574.57 | 536.36 | Upgrade
|
| Unlevered Free Cash Flow | 471.63 | 187.23 | 728.51 | 596.74 | 581.54 | 551.03 | Upgrade
|
| Change in Net Working Capital | -569.98 | -277.92 | -583.18 | -364.97 | -361.91 | -348.56 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.